MedTrace Logo

Carpal Tunnel/Amyloidosis Blood Sample Study

NCT02587728 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2021-08-26

No results posted yet for this study

Summary

Carpal tunnel is an early manifestation of amyloidosis in a significant minority of patients. This specimen collection protocol will allow the investigators to screen patients with carpal tunnel syndrome for amyloidosis.

Conditions

  • Carpal Tunnel Syndrome
  • Amyloidosis

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • James Hoffman, MD · University of Miami

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-24
Primary Completion
2017-02-07
Completion
2017-02-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02587728 on ClinicalTrials.gov